Clinical Trial Update: Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial mapping iron levels in the substantia nigra across Parkinson disease, REM sleep behavior disorder, and healthy controls, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Rem Sleep Behavior Disorder

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Parkinson Disease, REM Sleep Behavior Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-12